Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and PresentationsGlobeNewsWire • 07/17/26
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor FluctuationsGlobeNewsWire • 06/29/26
Why Amneal Pharmaceuticals (AMRX) is a Top Momentum Stock for the Long-TermZacks Investment Research • 06/24/26
AMNEAL PHARMACEUTICALS, INC. (AMRX) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 06/11/26
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal PharmaceuticalsPRNewsWire • 06/10/26
Amneal Pharmaceuticals, Inc. (AMRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's DiseaseGlobeNewsWire • 06/05/26
Amneal Pharmaceuticals gets FDA approval for romidepsin injection solutionProactive Investors • 06/04/26
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026GlobeNewsWire • 06/01/26
Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-TermZacks Investment Research • 05/18/26
Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)Zacks Investment Research • 05/08/26